AADvac 2

Drug Profile

AADvac 2

Alternative Names: AADvac-2; AAdvac2; Alzheimer's passive vaccine - Axon Neuroscience

Latest Information Update: 30 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Axon Neuroscience
  • Developer Axon Neuroscience; LifeArc
  • Class Alzheimer vaccines; Monoclonal antibodies
  • Mechanism of Action Tau protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Alzheimer's disease

Most Recent Events

  • 15 Jun 2017 MRC Technology is now called LifeArc
  • 11 Nov 2015 Preclinical trials in Alzheimer's disease in Slovakia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top